摘要
目的４０例肺癌心包积液引流与局部及全身化疗的临床分析。方法第一组８例单纯引流，第二组１９例引流＋腔内化疗（５┐ＦＵ７５０ｍｇ＋顺铂６０ｍｇ或表阿霉素４０ｍｇ＋顺铂６０ｍｇ～７０ｍｇ），第三组１３例引流＋腔内化疗（同第二组）＋全身化疗（ＭＶＰ方案或ＭＥＰ方案）。结果第一组平均生存期４月，第二组４．３５月，第三组８．３１月。第三组优于其他二组（Ｐ＜０．０５）。结论肺癌癌性心包积液只要及时诊断，采取有效综合措施，则能缓解症状，并且提高生存期和生存质量。
bjective:Clinical analysis was done with 40 cases of lung cancer hydropericardium.Methods:Group 1(n=8 cases)was treated with simple draining;Group2(n=19) with draining plus intrapericardium chemotherapy(5FU 750 mg+cisplatin 60 mg, or epiadriamycin 40 mg+cisplatin 60 mg～70 mg);Group 3(n=13)with draining plus intrapericardium chemotherapy(same as group 2) and plus systemic chemotherapy (project MVP or MEP). Result:Average survival time for group 1 was 4 months, for group 2 4.35 months, and for group 3 8.31 months.Group 3 was longer than 1 and 2 (P<005).Conclusion:As for lung cancer hydropericardium, timely diagnosis and efficient comprehensive measure can somewhat remit the symptoms and prolong the survival time.
出处
《肿瘤》
CAS
CSCD
北大核心
1998年第2期88-89,共2页
Tumor
